🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Dolutegravir is a potent integrase strand transfer inhibitor. Abacavir/dolu...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-06-06
Trial ID
NCT03016533
Dolutegravir (DTG) is an HIV drug in the integrase inhibitor drug class. Th...
Status
Completed
Location
University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program (Site ID: 4601)
Start Date
2011-04-20
Trial ID
NCT01302847
This is an open-label, randomized, crossover study in healthy adult subject...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-09-01
Trial ID
NCT02893488
Treatments Being Tested
This study aims to find out whether treating children and young people livi...
Status
Active Not Recruiting
Location
King Edward VIII Hospital
Start Date
2022-04-22
Trial ID
NCT04337450
Treatments Being Tested
This study aims to find out whether treating children living with HIV with ...
Status
Completed
Location
Baylor College of Medicine Children's Foundation
Start Date
2024-12-11
Trial ID
NCT05993767